The Lancet. Psychiatry, 2215-0366

Journal

View graph of relations

Related Publications
  1. High-potency cannabis and incident psychosis: correcting the causal assumption

    Sommer, I. E. & van den Brink, W., Jun-2019, In : The Lancet. Psychiatry. 6, 6, p. 464-465 2 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  2. Antipsychotic treatments: who is really failing here? Reply

    Kahn, R. S. & Sommer, I. E., Oct-2018, In : The Lancet. Psychiatry. 5, 10, p. 785-786 2 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  3. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

    OPTIMISE Study Grp, Oct-2018, In : The Lancet. Psychiatry. 5, 10, p. 797-807 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Preventive strategies for mental health

    Arango, C., Diaz-Caneja, C. M., McGorry, P. D., Rapoport, J., Sommer, I. E., Vorstman, J. A., McDaid, D., Marin, O., Serrano-Drozdowskyj, E., Freedman, R. & Carpenter, W., 1-Jul-2018, In : The Lancet. Psychiatry. 5, 7, p. 591-604 14 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  5. Data do not support sex as addictive

    Prause, N., Janssen, E., Georgiadis, J., Finn, P. & Pfaus, J., Dec-2017, In : The Lancet. Psychiatry. 4, 12, p. 899-899 1 p.

    Research output: Contribution to journalLetterAcademicpeer-review

View all (14) »

ID: 19941134